Optimi Health is trading at $2.64, down 5.04%, with no clear company-specific catalyst identified for the October 29 decline.

  • The latest company announcements found were an October 26 Australian subsidiary update and October 20 MDMA production news.
  • Major U.S. indices were lower.
  • Available evidence does not establish that broader market weakness caused Optimi Health’s move.